Stock listing

Kyowa Kirin Co., Ltd.

Selected listing: KY4 · SWB · EUR · DE

Kyowa Kirin Co., Ltd. (Stuttgart:KY4), Health Technology. Latest release Sep 29, 2026: Kyowa Kirin and Knight Therapeutics Enter Into Exclusive Distribution…

KY4:SWBEURDEUpdated October 3, 2026

Ticker: Stuttgart:KY4
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Stuttgart
Currency: EUR

Latest news from Kyowa Kirin Co., Ltd.

Kyowa Kirin and Knight Therapeutics Enter Into Exclusive Distribution Agreement for POTELIGEO® (mogamulizumab) for Cutaneous T-Cell Lymphoma (CTCL) Patients Across Latin America

September 29, 2026

Kyowa Kirin Announces Agreement with U.S. Administration to Reduce Treatment Costs for Americans

August 31, 2026

Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2026 Semi Annual

August 3, 2026

European Commission Approves Crysvita® (burosumab) for Infants with X-linked Hypophosphataemia in the European Union

July 21, 2026

FDA Selects Kyowa Kirin for PreCheck Pilot Program to Accelerate Manufacturing Timelines and Enhance Supply Chain Resilience

June 30, 2026

All Kyowa Kirin Co., Ltd. news →

Research Kyowa Kirin Co., Ltd.

Kyowa Kirin Co., Ltd. company profile

View the public company page for Kyowa Kirin Co., Ltd. on 6ix.

Kyowa Kirin Co., Ltd. news

Read company news and market updates connected to Kyowa Kirin Co., Ltd..

Kyowa Kirin Co., Ltd. investor events

Find investor webinars, events, and replay context for Kyowa Kirin Co., Ltd..